Education

• MD, Medical School of Munich, 1973
• PhD, University of Munich, Germany, 1975
• Fellowship, Immunobiology Research, University of Wisconsin Hospital and Clinics, Madison, WI, 1975-1976
• Residency, University of Wisconsin Hospital and Clinics, Madison, WI, 1976-1980

Professional Activities

Dr. Sollinger is on the editorial board of several international academic journals, including Transplantation and the Journal of the American College of Surgeons.
He holds offices for the following national and international professional societies:

• American Society of Transplant Surgeons (past-president)
• International Society of Organ Sharing (past-president)
• The Transplantation Society (treasurer)

Clinical Specialties

Dr. Sollinger is certified by the American Board of Surgery. He specializes in kidney and pancreas transplantation as well as total pancreatectomy and islet autotransplantation as a treatment for chronic pancreatitis.

Dr. Sollinger provides a wide range of services including Kidney Transplant, Pancreas Transplant, and Pediatric Kidney Transplant.

Research Interests

Dr. Sollinger’s research interests include the clinical and preclinical testing of new immunosuppressive agents and gene therapy for cell transplantation.

Active Clinical Trials

• A Partially Blinded, Prospective, Randomized Multicenter Study Evaluating Efficacy, Safety and Tolerability of Oral Sotrastaurin Plus Standard or Reduced Exposure Tacrolimus vs. Mycophenolic Acid Plus Tacrolimus in de Novo Renal Transplant Recipients
  Principal Investigator(s): Hans W. Sollinger, MD, PhD, FACS
  Status: Active, not recruiting
  [ClinicalTrials.gov: NCT01064791]
  More Information
• Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation
  Principal Investigator(s): William J Burlingham, PhD, Hans W. Sollinger, MD, PhD, FACS
  Status: Recruiting
  [ClinicalTrials.gov: NCT01053221]
  More Information
• Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation
  Principal Investigator(s): Hans W. Sollinger, MD, PhD, FACS
  Status: Recruiting
  [ClinicalTrials.gov: NCT01035593]
  More Information

Recent Publications

• Pretransplant immune regulation predicts allograft outcome: bidirectional regulation correlates with excellent renal transplant function in living-related donor-recipient pairs.
  Jankowska-Gan E, Sheka A, Sollinger HW, Pirsch JD, Hofmann RM, Haynes LD, Armbrust MJ, Mezrich JD, Burlingham WJ
  Transplantation 2012 Feb 15; 93(3):283-90.
  [PubMed ID: 22186938]
  More Information
• The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience.
  Singh N, Neidlinger N, Djamali A, Leverson G, Voss B, Sollinger HW, Pirsch JD
  Clinical transplantation 2012 Jan 29.
  [PubMed ID: 22283142]
  More Information
• Simultaneous pancreas and kidney (SPK) retransplantation in prior SPK recipients.
  Lamattina JC, Sollinger HW, Becker YT, Mezrich JD, Pirsch JD, Odorico JS
  Clin Transplant 2011 Oct 28.
  [PubMed ID: 22032238]
  More Information
• Donation after cardiac death: a 29-year experience.
  Bellingham JM, Santhanakrishnan C, Neidlinger N, Wai P, Kim J, Niederhaus S, Leverson GE, Fernandez LA, Foley DP, Mezrich JD, Odorico JS, Love RB, De Oliveira N, Sollinger HW, D'Alessandro AM
  Surgery 2011 Oct; 150(4):692-702.
  [PubMed ID: 22000181]
  More Information
• Luminex-based desensitization protocols: the University of Wisconsin initial experience.
  Niederhaus SV, Muth B, Lorentzen DF, Wai P, Pirsch JD, Samaniego-Picota M, Leverson GE, D'alessandro AM, Sollinger HW, Djamali A
  Transplantation 2011 Jul 15; 92(1):12-7.
  [PubMed ID: 21512428]
  More Information